Vitamin D Deficiency

4
Pipeline Programs
4
Companies
5
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
1
0
1
1
1
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

3 companies ranked by most advanced pipeline stage

M&
Merck & Co.RAHWAY, NJ
2 programs
1
1
cholecalciferolPhase 31 trial
MK0822APhase 21 trial
Active Trials
NCT00242476Completed216Est. Jul 2006
NCT00681590Completed105Est. Apr 2009
Faes Farma
Faes FarmaSpain - Leioa
1 program
1
Calcifediol 75mcgPhase 2/31 trial
Active Trials
NCT04735926Completed674Est. Apr 2023
Pfizer
PfizerNEW YORK, NY
2 programs
1
cholecalciferolPhase 11 trial
cholecalciferolN/A1 trial
Active Trials
NCT01508845Completed61Est. Jun 2013
NCT01268176Completed62Est. Jun 2012

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Merck & Co.cholecalciferol
Faes FarmaCalcifediol 75mcg
Merck & Co.MK0822A
Pfizercholecalciferol
Pfizercholecalciferol

Clinical Trials (5)

Total enrollment: 1,118 patients across 5 trials

NCT00681590Merck & Co.cholecalciferol

Safety of Vitamin D Supplementation in Older Persons

Start: Apr 2008Est. completion: Apr 2009105 patients
Phase 3Completed
NCT04735926Faes FarmaCalcifediol 75mcg

Efficacy and Safety of Calcifediol vs Placebo in Subjects With Vitamin D Deficiency

Start: Dec 2020Est. completion: Apr 2023674 patients
Phase 2/3Completed

A Study to Assess the Effectiveness of an Investigational Drug in Elderly Subjects With Low Vitamin D Levels (0822A-009)

Start: Sep 2005Est. completion: Jul 2006216 patients
Phase 2Completed
NCT01268176Pfizercholecalciferol

The Effect of a Meal on Vitamin D Absorption

Start: Dec 2010Est. completion: Jun 201262 patients
Phase 1Completed
NCT01508845Pfizercholecalciferol

A Pilot Study of the Effect of Dietary Fat Type and Amount on Vitamin D3 Absorption

Start: Jan 2012Est. completion: Jun 201361 patients
N/ACompleted

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 late-stage (Phase 3) programs — potential near-term approvals
4 companies competing in this space